Mogamulizumab + Low-Dose Total Skin Electron Beam Tx in Mycosis Fungoides & Sézary Syndrome
Status:
Recruiting
Trial end date:
2022-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy of the combination of LD-TSEBT and
mogamulizumab in patients with MF and SS. And to evaluate the secondary measures of clinical
benefit of the combination therapy and to evaluate the safety and tolerability of the
combination in patients with MF and SS.